Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary Fibrosis
Clinical trial NCT07192939 · RECRUITING
Trial details
- NCT number
- NCT07192939
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-29
- Primary completion
- 2028-06-01
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.